Clinical trial
The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in…
NCT00125957 · Mclean Hospital, Other · Completed
Key facts
| NCT number | NCT00125957 |
|---|---|
| Title | The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression |
| Official title | The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression |
| Lead sponsor | Mclean Hospital, Other |
| Collaborators | National Association for Research on Schizophrenia and Affective Disorders. |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depression, Major Depressive Disorder, Unipolar Depression |
| Intervention type | Drug |
| Interventions | Wellbutrin, Placebo |
| Enrollment | 32 |
| Start date | Aug 1, 2005 |
| Primary completion | Jan 1, 2010 |
| Completion | Dec 1, 2011 |
| First posted | Aug 2, 2005 |
| Last update posted | Aug 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: